Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido
Toshimi
T
Takada
Yasutsugu
Y
Uemoto
Shinji
S
D015415:Biomarkers / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality; D019520:Living Donors; D009367:Neoplasm Staging; D018579:Patient Selection; D011237:Predictive Value of Tests; D011498:Protein Precursors / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D012008:Recurrence; D018570:Risk Assessment
D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; C008208:acarboxyprothrombin; D011516:Prothrombin